Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SEEC, Inc. (SEEC) -- Ignore unavailable to you. Want to Upgrade?

To: John Sikora who wrote (291)	5/21/1998 10:45:00 AM
From: joe smith	Read Replies (2) \| Respond to of 1031

john, have you seen a balance sheet from the most recent march quarter yet? js

To: John Sikora who wrote (291)	5/21/1998 10:55:00 AM
From: Ron Sirch	Read Replies (1) \| Respond to of 1031

The Wainwright Research Report was written by Alex Arnold. IMO, one of the best Y2k analysts. The first excerpt follows: Investment Opinion SEEC continues to deliver on its strategic plan, effectively leveraging the year 2000 problem to gain mindshare in the software reengineering market and to add rapidly to its existing customer base. The company has, time and time again, demonstrated the ability to rapidly release value-added software products in line with emerging market demand, evidenced by the initial release of COBOL Analyst, followed by conversion technology (Smart Change), and most recently with the release of AccuTest for testing. The final stage of development of the company's next-generation non-Y2k products was accelerated in Q4 in order to keep pace with developing market trends in future quarters. SEEC has the market vision and technical expertise to maintain a 35% secular growth rate with continued enhancement to its core technology and additional product introductions. SEEC's shares are currently discounted to its fair value, trading at 28 times latest-four-quarters earnings of $0.46. We strongly recommend the purchase of SEEC's shares with a twelve month target price of $23, based upon a multiple of 35 times our fiscal 1999 EPS estimate (ending Mar. '99) of $0.65.